PJT News and Press, PJT Partners Inc. Class A From 05/02/24

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

Placental Mucosal Associated Invariant T (MAIT) cells are unique unconventional immune T cells which are particularly suitable for the treatment of solid tumors, a significant unmet medical need MAIT cells offer unique advantages compared to conventional T cells MAIT cells hold immense po...

First Quarter Overview Record First Quarter Revenues of $329 million, an increase of 65% from a year ago GAAP Pretax Income of $54 million and Adjusted Pretax Income of $55 million, an increase of 85% and 81%, respectively, from a year ago GAAP Diluted EPS of $1.22 and Adjusted EP...

2024-05-01 12:31:44 ET More on PJT Partners PJT Partners: Early In The Wave PJT Partners Inc. (PJT) Q4 2023 Earnings Call Transcript PJT Partners cut to Sell as UBS sees limited earnings growth PJT Partners Q4 2023 Earnings Preview Seeking Alphaȁ...

PJT Partners Inc. (“PJT Partners”) (NYSE:PJT) announced that it expects to release its first quarter 2024 financial results on Thursday morning, May 2, 2024. The earnings release will be available through the Investor Relations section of the PJT Partners website at www.pjtpartner...

2024-04-13 22:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Pluri’s patent enables mass-scale production of immune cell therapies New patented technology is applicable for the expansion of a variety of immune cells Technology sets stage for potential immune cell therapy advancements and targets an estimated total addressable market of $11...

HAIFA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Pluri Inc . (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote global wellbeing and sustainability, today announced leadership from its business verticals wil...

HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) ("Pluri" or the “Company"), a leading biotechnology company that transforms cells into solutions, today announced that a reverse share split of the Company’s issued and outstanding common shares...

2024-03-26 12:16:24 ET More on PJT Partners PJT Partners: Early In The Wave PJT Partners Inc. (PJT) Q4 2023 Earnings Call Transcript PJT Partners Q4 2023 Earnings Preview Goldman turns bearish on Perella Weinberg Partners, neutral on PJT Partners Seek...